1. hockeynutz4
2. er09
3. bkmetzfrontierco
4. Fibonacci
5. adelaydpec9
1.johnknickerb 02/07/2018
FDA approves Biktarvy for treatment of HIV-1
2.er09 02/22/2018
Long news? - J.P. Morgan Weighs in on Sangamo Therapeutics Inc's (SGMO) Collaboration with Kite
3.bkmetzfrontierco 01/31/2018
Finbox.io points out that Gilead shares are ultra cheap compared to their peers right now.
4.adelaydpec9 03/07/2018
Gilead Presents Data From Phase 3 Study Evaluating Women Who Switched to Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) From a Boosted Protease Inhibitor-Based Regimen or Boosted Elv
5.ppfef80 03/05/2018
Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope Targeting Antibody in SHIV-Infected, Virally Suppressed
6.blackclouds 10/19/2017
$GILD......... 51% of patients that recieved Yescarta are in complete remission
7.adelaydpec9 02/22/2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
8.Fibonacci 10/18/2017
price set at $373,000
9.TheGriper 02/18/2018
A federal judge in Delaware has overturned a jury's verdict
10.hockeynutz4 02/07/2018
Nice to see them taking action
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW